Armed private police patrolling Cleveland’s medical zone and the city streets around it disproportionately charge and cite Black people, even though most hospital employees, patients and visitors are white.
Armed private police patrolling Cleveland’s medical zone and the city streets
around it disproportionately charge and cite Black people, even though most
hospital employees, patients and visitors are white.
Local elected officials and the NAACP are calling for tougher supervision of
private police forces, including one run by the Cleveland Clinic, after
ProPublica found that these officers disproportionately arrest Black people.
Local elected officials and the NAACP are calling for tougher supervision of private police forces, including one run by the Cleveland Clinic, after ProPublica found that these officers disproportionately arrest Black people.
Michael Holick, a renowned scientist turned expert witness, relies on his own
controversial theory to help alleged abusers avoid prison and regain custody of
the babies they were accused of harming.
Lax states are attracting shoppers and students from stricter neighbors — and sending back COVID-19 cases. The imbalance underscores the lack of a national policy.
Lax states are attracting shoppers and students from stricter neighbors — and
sending back COVID-19 cases. The imbalance underscores the lack of a national
policy.
A settlement is about to shield members of the Sackler family from civil litigation regarding their alleged roles in the opioid crisis. So it’s a good time to release the full video of Richard Sackler’s 2015 deposition.
St. Jude Children’s Research Hospital promises not to bill families. But the cost of having a child at the hospital for cancer care leaves some families so strapped for money that parents share tips on spending nights in the parking lot.
When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.
Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize those companies that sell their drugs at higher prices than the average of the prices in other wealthy nations.
